title: Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin.
authors.forename: R
authors.initials: R
authors.lastname: Lenzi
authors.forename: M N
authors.initials: MN
authors.lastname: Raber
authors.forename: P
authors.initials: P
authors.lastname: Frost
authors.forename: S
authors.initials: S
authors.lastname: Schmidt
authors.forename: J L
authors.initials: JL
authors.lastname: Abbruzzese
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy*
chemical_list: D002945:Cisplatin; D002955:Leucovorin; D005472:Fluorouracil